The U.S. Food and Drug Administration has approved Prolia to promote bone strength and reduce the risk of fractures in postmenopausal women. Prolia is an injectable drug taken once every six months that works by blocking cells responsible for breaking down bones.
How common is it for patients to have difficulty tolerating oral bisphosphonates?The difficulties with oral bisphosphonates became known... Read more »
For those dissatisfied with current drug options for treating osteoporosis: a new medication being developed by Amgen may be making headway... Read more »
Pharmaceutical company Amgen has just released more positive findings for denosumab, a new osteoporosis drug in development. The latest... Read more »
When Michelle Easton, 56, was diagnosed with osteoporosis five years ago, her doctor prescribed Fosamax. Michelle was diligent about taking... Read more »
Around half of people over 50 have osteoporosis. Regardless of age, however, there are millions who have early onset or great risk. If you... Read more »
Osteoporosis is a disease that causes bones to weaken and break. The most common bones affected are the hip, wrist and vertebrae. Approximately 10... Read more »
Source: ADAM Encyclopedia
Thin bones Treatment The goals of osteoporosis treatment are to: Control pain from the disease Slow down or stop bone loss ... Read more »
Source: HealthCentral Encyclopedia
Osteoporosis is a disease of the bones characterized by a decrease in bone mass and structural deterioration of bone tissue, leading to bone... Read more »
Once-a-year injections of a common osteoporosis med could greatly reduce older women's fracture risk, a new study suggests. Researchers in Texas say... Read more »
The U.S. Food and Drug Administration has approved Reclast for the treatment and prevention of steroid-induced osteoporosis. The once-yearly... Read more »